Vaccines | Free Full-Text | Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up
RACGP - Chronic hepatitis B – what's new?
COVID-19 factsheet for people with hep B & hep C | Hepatitis NSW
Core Concepts - HBV Immunizations - Prevention of HBV - Hepatitis B Online
Three-Dose Hepatitis B Vaccine Regimen Protects People with HIV | Today's Clinical Lab
Hepatitis vaccination update | MDedge Family Medicine
Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study - The Lancet Global Health
With eyes on Glaxo's Engerix-B vaccine, VBI takes hep B candidate into phase 3 | Fierce Pharma
Chronic hepatitis B in remote, tropical Australia; successes and challenges | PLOS ONE
HBsAg - Wikipedia
Data linkage and computerised algorithmic coding to enhance individual clinical care for Aboriginal people living with chronic hepatitis B in the Northern Territory of Australia – Is it feasible? | PLOS ONE
Vaccines | Free Full-Text | Cross-Protection of Hepatitis B Vaccination among Different Genotypes
Vaccines | Free Full-Text | Effect of a Community-Based Hepatitis B Virus Infection Detection Combined with Vaccination Program in China
An open letter to Gavi: hepatitis B birth dose vaccine can't wait | Hepatitis Australia
Modeling Progress Toward Elimination of Hepatitis B in Australia - McCulloch - 2020 - Hepatology - Wiley Online Library
Why hepatitis B hits Aboriginal Australians especially hard
Why Universal Hepatitis B Vaccination Isn't Quite Universal | Science-Based Medicine
What is Hepatitis B and should we be giving it to newborns? – MTHFR Support Australia
Hepatitis B – MTHFR Support Australia
Unraveling the complexity of hepatitis B virus: From molecular understanding to therapeutic strategy in 50 years - ScienceDirect
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook | Nature Reviews Gastroenterology & Hepatology
Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges.
HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus Infection | ACS Infectious Diseases
